BRPI0413682A - compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos - Google Patents

compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos

Info

Publication number
BRPI0413682A
BRPI0413682A BRPI0413682-9A BRPI0413682A BRPI0413682A BR PI0413682 A BRPI0413682 A BR PI0413682A BR PI0413682 A BRPI0413682 A BR PI0413682A BR PI0413682 A BRPI0413682 A BR PI0413682A
Authority
BR
Brazil
Prior art keywords
compounds
methods
extermination
microorganism
pharmaceutical composition
Prior art date
Application number
BRPI0413682-9A
Other languages
English (en)
Inventor
Laurence Mark Von Itzstein
Christopher Bonner Davis
Robin Joy Thomson
Regan David Hartnell
Paul David Orr Madge
Original Assignee
Univ Griffith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003904500A external-priority patent/AU2003904500A0/en
Application filed by Univ Griffith filed Critical Univ Griffith
Publication of BRPI0413682A publication Critical patent/BRPI0413682A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/14Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

"COMPOSTOS, COMPOSIçãO FARMACêUTICA E RESPECTIVOS MéTODOS DE PREPARAçãO DE TRATAMENTO DE INFECçãO MICROBIANA E DE EXTERMìNIO DE MICROORGANISMO E USOS". São apresentados compostos de óxido de sulfenamida da fórmula geral (I), em que A, R~ 1~, R~ 2~, X~ 1~, X~ 1~<39>, X~ 2~, X~ 2~<39>, X~ 3~, X~ 4~, X~ 4~<39>, X~ 5~ e X~ 5~<39> definem muitas variáveis e em que q é O ou 1 e p é 1 ou 2. Os compostos apresentados nos exemplos são os compostos de óxido de sulfenamida galactofuranosil e glucofuranosil, em que a variável A é o oxigenio. Também são apresentados métodos de síntese dos compostos de fórmula geral (I), composições farmacêuticas que os contenham e métodos de uso no tratamento de pacientes que estejam sofrendo de infecção microbiana.
BRPI0413682-9A 2003-08-21 2004-08-20 compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos BRPI0413682A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2003904500A AU2003904500A0 (en) 2003-08-21 Novel compounds II
AU2003904501A AU2003904501A0 (en) 2003-08-21 Novel compounds III
PCT/AU2004/001110 WO2005019236A1 (en) 2003-08-21 2004-08-20 Novel sulfenamide oxides

Publications (1)

Publication Number Publication Date
BRPI0413682A true BRPI0413682A (pt) 2006-10-24

Family

ID=34218927

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413682-9A BRPI0413682A (pt) 2003-08-21 2004-08-20 compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos

Country Status (7)

Country Link
EP (1) EP1664071A1 (pt)
JP (1) JP2007502778A (pt)
BR (1) BRPI0413682A (pt)
CA (1) CA2535800A1 (pt)
MX (1) MXPA06001974A (pt)
RU (1) RU2006108577A (pt)
WO (1) WO2005019236A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601716B2 (en) 2006-05-01 2009-10-13 Cephalon, Inc. Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
SG171914A1 (en) 2008-12-02 2011-07-28 Chiralgen Ltd Method for the synthesis of phosphorus atom modified nucleic acids
EP2451461A4 (en) 2009-07-06 2013-05-29 Ontorii Inc NOVEL NUCLEIC ACID PRODRUGS AND METHOD OF USE THEREOF
DK2620428T3 (da) 2010-09-24 2019-07-01 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
US9605019B2 (en) 2011-07-19 2017-03-28 Wave Life Sciences Ltd. Methods for the synthesis of functionalized nucleic acids
DK2872485T3 (da) 2012-07-13 2021-03-08 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
KR102423317B1 (ko) 2014-01-16 2022-07-22 웨이브 라이프 사이언시스 리미티드 키랄 디자인
WO2018035380A1 (en) 2016-08-17 2018-02-22 Solstice Biologics, Ltd. Polynucleotide constructs
WO2019006455A1 (en) 2017-06-30 2019-01-03 Solstice Biologics, Ltd. AUXILIARIES OF CHIRAL PHOSPHORAMIDITIS AND METHODS OF USE THEREOF
MX2022006865A (es) 2019-12-06 2022-07-11 Vertex Pharma Tetrahidrofuranos sustituidos como moduladores de canales de sodio.
CN115666553A (zh) 2020-05-27 2023-01-31 轴向治疗公司 Tlr2调节剂化合物及其药物组合物和用途
CN117794920A (zh) 2021-06-04 2024-03-29 沃泰克斯药物股份有限公司 N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04008124A (es) * 2002-02-22 2005-09-08 Univ Griffith Un agente antimicrobiano.

Also Published As

Publication number Publication date
WO2005019236A1 (en) 2005-03-03
JP2007502778A (ja) 2007-02-15
CA2535800A1 (en) 2005-03-03
MXPA06001974A (es) 2006-05-31
RU2006108577A (ru) 2007-09-27
EP1664071A1 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
NO20074657L (no) Nitrogenholdige aromatiske ringforbindelser
SE0104340D0 (sv) New compounds
ATE242213T1 (de) Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
ATE221521T1 (de) Azolylpiperazinylphenyloxazolidinone als antimikrobielle mittel
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
BR0313266A (pt) Compostos, respectivos processos de preparação e uso, formulação farmacêutica e métodos de prevenção e/ou tratamento de um distúrbio mediado pelo receptor de mglur5 e de inibição da ativação de receptores de mglur5
MY140488A (en) Substituted oxazolidinones and their use in the field of blood coagulation
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
AP2003002915A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
BR0014596A (pt) Derivado de pirimidina, uso do mesmo, composição farmacêutica, e, método de tratar doenças ou condições médicas mediadas por citocinas
BRPI0411582A (pt) substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso
SE0001899D0 (sv) New compounds
SE0104251D0 (sv) Novel compounds
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
AU2002248384A1 (en) Serpin drugs for treatment of hiv infection and method of use thereof
PL354030A1 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
DE60211539D1 (de) Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
YU40002A (sh) Antipikornavirusna jedinjenja i kompozicije, njihove farmaceutske upotrebe, i materijali za njihove sinteze
BRPI0413684A (pt) compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
SE9902765D0 (sv) Novel compounds
SE9903894D0 (sv) Novel compounds

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired